A 6-month, open-label study of memantine
โ
Janine Diehl-Schmid; Hans Fรถrstl; Robert Perneczky; Corina Pohl; Alexander Kurz
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 72 KB
## Abstract ## Objective To evaluate safety and effects on cognition and behavior of memantine 20โmg/day in the treatment of patients with frontotemporal dementia (FTD). ## Methods This was a singleโcenter, 6โmonth, open, uncontrolled study. Sixteen outpatients with a diagnosis of FTD were enrol